In this study, the positive percentage of CD43 and CD180 was more sensitive than previous scores (Moreau score and CLLflow score) in the diagnosis of atypical CLL and CD5 negative or CD23 negative CLL. This evidence concerns the gene SPN and B-cell chronic lymphocytic leukemia.